Delaware Wegener's
Infusion Center of DE
Rheumatologist for Wegeners in Infusion Center of DE
Vasculitis is a group of rare disorders involving inflammation of the blood vessels. When blood vessels become inflamed, they can thicken, narrow, or scar, reducing blood flow to critical organs and tissues. This can lead to serious complications including tissue and organ damage.
One of the most serious forms of vasculitis is Wegener’s Granulomatosis, now called Granulomatosis with Polyangiitis (GPA). This condition requires early diagnosis and targeted treatment to avoid life-threatening complications.
At Delaware Infusion Center, we are committed to providing innovative therapies that foster long-term health, effective disease management, and the improvement of blood vessel function to enhance patient well-being.
What is Wegener's?
Infusion therapy may be recommended for patients with active, relapsing, or organ-threatening GPA. The primary goal is to reduce inflammation, prevent permanent organ damage, and achieve long-term disease control while minimizing treatment-related complications.
Every patient experiences GPA differently some have mild symptoms affecting only the upper respiratory tract, while others develop inflammation involving the kidneys, lungs, or multiple organ systems. Because of this variation, treatment plans are personalized rather than standardized. Providers may consider infusion therapy for patients who:
- Have moderate to severe disease activity
- Experience disease relapse after previous treatment
- Have kidney, lung, or other major organ involvement
- Require biologic therapy to induce or maintain remission
- Need an alternative to medications that haven't adequately controlled inflammation
Which Medications Are Commonly Given by Infusion?
Several medications used to treat GPA can be administered by IV infusion. The specific medication depends on the patient’s condition, medical history, treatment goals, and recommendations from the prescribing specialist.
- Rituximab
One of the most commonly prescribed biologics for GPA. It’s a monoclonal antibody that targets CD20-positive B cells, helping decrease the autoimmune response responsible for blood vessel inflammation.
Depending on the individual’s clinical situation, treatment plans may also include intravenous corticosteroids or other immunosuppressive therapies, selected based on current clinical guidelines, disease severity, and overall health. Because these therapies influence immune system function, patients require careful monitoring before, during, and after treatment.
What to Expect During Infusion Therapy
Most infusion appointments follow a structured process: a health assessment, IV access, medication administration, and ongoing observation by trained healthcare professionals. Appointment length depends on the medication and the patient’s individual treatment plan.
- Before Treatment
Staff review medical history, current medications, allergies, and recent illnesses, and check vital signs to confirm it’s safe to proceed.
- During Treatment
Medication is delivered through an IV line at a controlled rate while staff monitor for comfort and any signs of infusion-related reaction.
Following treatment, patients receive instructions about possible side effects, follow-up care, and when to contact their healthcare provider.
How Is Wegener's Disease Monitored?
Long-term monitoring is essential. Regular follow-up appointments, lab testing, and clinical evaluations help providers determine whether treatment is effectively controlling inflammation while identifying potential complications early.
Patients should promptly report new symptoms such as fever, persistent cough, shortness of breath, blood in the urine, worsening fatigue, or unexplained weight loss, as these may indicate disease activity or infection requiring medical evaluation.
- Complete blood count (CBC)
- Kidney and liver function tests
- Urinalysis
- Inflammatory markers and ANCA testing
- Imaging studies if symptoms change
- Assessment of disease activity and organ function
Benefits and Risks of Infusion Therapy
- Better control of blood vessel inflammation
- Reduced risk of disease progression
- Lower likelihood of irreversible organ damage
- Support for achieving or maintaining remission
- Reduced reliance on long-term corticosteroids
- Infusion-related reactions
- Increased susceptibility to infections
- Allergic reactions
- Fatigue following treatment
- Medication-specific side effects
Can Wegener's Disease Go Into Remission?
Yes. Many people with GPA achieve remission with appropriate treatment, although remission does not mean the disease has been cured. Ongoing medical care, regular monitoring, and adherence to the prescribed treatment plan help reduce the risk of relapse and protect long-term organ function.
Remission means active inflammation has been brought under control and symptoms have significantly improved or disappeared. However, GPA is a chronic autoimmune disease, and some patients may experience disease flares months or even years after achieving remission
- How early treatment began
- Severity of organ involvement
- Response to medication
- Adherence to follow-up care
- Overall health and other medical conditions
Symptoms
Wegeners or Granulomatosis with polyangiitis (GPA) symptoms can vary, but common ones include
- Fever, fatigue, and weight loss.
- Muscle aches and joint stiffness.
Ear, Nose, and Throat
Nasal drainage, sores, stuffiness, sinus infections, nosebleeds, earaches, and inflammation in the nose or ear cartilage.
Lung and Windpipe
Coughing (sometimes with blood), shortness of breath, wheezing, hoarseness, and stridor (high-pitched sound).it. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Kidney
High blood pressure, leg swelling, and blood in urine.
Eye
Redness, burning, pain, blurry/double vision, and bulging/swollen eyelids.
Other Symptoms
Numbness, tingling, rashes (purple spots), and digestive issues like stomach pain or diarrhea.
Treatment
Treatment for granulomatosis with polyangiitis (GPA) includes medicines to get the disease under control and keep it from coming back. Along with getting care from your regular healthcare professional, you’ll likely need treatment and follow-up care from various specialists. The specialists that you need depend on the organs that the disease affects. With early treatment, many people who have GPA get better and lead full lives.
Medication
Corticosteroids reduce inflammation and immune response but may cause weight gain, increased infection risk, and thinning bones.
Other immune-suppressing medicines include:
- Rituximab (Rituxan)
- Azathioprine (Azasan, Imuran)
- Mycophenolate (CellCept)
- Methotrexate (Trexall)
- Cyclophosphamide
- Avacopan (Tavneos)
Once controlled, long-term meds like rituximab, methotrexate, azathioprine, and mycophenolate help prevent relapse. These can increase infection risk, and cyclophosphamide may cause stomach issues, diarrhea, and hair loss. Your doctor may prescribe other meds to manage side effects.
At Infusion Center of DE, we provide prompt, specialized care for Wegeners or Granulomatosis with Polyangiitis (GPA), a rare condition affecting blood vessels. We address inflammation in organs such as the nose, sinuses, throat, lungs, and kidneys, while managing the symptoms of granuloma formation. Our approach is focused on improving blood flow and preventing organ damage to promote your long-term health and well-being. We tailor treatment plans to meet your specific needs, helping to reduce flare-ups and preserve organ function.
Long-Term Management
Long-term management focuses on preventing disease flares, preserving organ function, minimizing medication-related side effects, and maintaining the best possible quality of life. Because GPA affects each person differently, management plans are individualized and may change over time.
Routine Follow-Up
Regular evaluations allow specialists to assess symptoms, review medications, and identify changes in disease activity before serious complications develop.
Laboratory Monitoring
Regular evaluations allow specialists to assess symptoms, review medications, and identify changes in disease activity before serious complications develop.
Medication Management
Some patients require maintenance therapy for months or years after remission to reduce relapse risk.
Preventing Infections
Many GPA treatments suppress parts of the immune system patients should promptly report signs of infection.
Healthy Lifestyle Habits
Although lifestyle changes cannot cure GPA, providers often encourage patients to eat a balanced diet, stay physically active when possible, get adequate sleep, avoid tobacco products, manage stress effectively, and attend all scheduled medical appointments supporting better overall health during treatment.
When Should You See a Healthcare Provider?
Persistent respiratory symptoms, unexplained fatigue, blood in the urine, chronic sinus problems, coughing up blood, or unexplained weight loss should be evaluated by a healthcare provider. Many early symptoms resemble common illnesses, making diagnosis difficult during the initial stages of the disease.
Seek prompt medical attention if you experience: blood in the urine, coughing up blood, persistent shortness of breath, chest pain, sudden vision changes, severe nosebleeds, persistent fever, unexplained weight loss, progressive fatigue, or new numbness or weakness.
Advances in Wegener's Disease Treatment
Medical research continues to improve the understanding and treatment of GPA. Over the past two decades, treatment has shifted from relying primarily on broad immunosuppressive medications to more targeted therapies, including:
- Improved biologic medications
- Better strategies for maintaining remission
- Reduced dependence on long-term corticosteroids
- Earlier diagnosis through improved laboratory testing
- More individualized treatment plans
- Enhanced monitoring for medication safety
long-term rituximab study in Granulomotosis with polyangitis (GPA)
- Source:
- PubMed →
Areas Infusion Center of DE Serves in Delaware
Wilmington
- 4512 Kirkwood Hwy Wilmington, Delaware, 19808
- Mon, Tues, Wed, Thur, Fri
- Mon: 08:00 AM - 05:00 PM
- Tue: 08:00 AM - 05:00 PM
- Wed: 08:00 AM - 05:00 PM
- Thu: 08:00 AM - 05:00 PM
- Fri: 08:00 AM - 04:00 PM
- Sat: Closed
- Sun: Closed
Dover
- 260 Beiser Blvd Dover, Delaware, 19904
- Mon, Tues, Wed, Thur, Fri
- Mon: 08:00 AM - 05:00 PM
- Tue: 08:00 AM - 05:00 PM
- Wed: 08:00 AM - 05:00 PM
- Thu: 08:00 AM - 05:00 PM
- Fri: 08:00 AM - 04:00 PM
- Sat: Closed
- Sun: Closed
Milford
- 2000 Brent Jordan Way Milford, Delaware, 19963
- Mon, Tues, Wed, Thur, Fri
- Mon: 08:00 AM - 05:00 PM
- Tue: 08:00 AM - 05:00 PM
- Wed: 08:00 AM - 05:00 PM
- Thu: 08:00 AM - 05:00 PM
- Fri: 08:00 AM - 04:00 PM
- Sat: Closed
- Sun: Closed
FAQS ABOUT WEGENERS - INFUSION CENTER OF DE
Granulomatous disease, including conditions like Granulomatosis with Polyangiitis (GPA), does not typically go away completely. While it can be managed with treatment, the disease often requires long-term care to control symptoms and prevent flare-ups. Treatment may include medications such as immunosuppressants and steroids. At Infusion Center of DE, various therapies are available to help manage granulomatous diseases and improve quality of life.
While there is no cure for Wegener’s disease (Granulomatosis with Polyangiitis), many people can recover and lead normal lives with proper treatment. Early diagnosis and ongoing therapy, such as immunosuppressants and steroids, can help manage symptoms, reduce flare-ups, and prevent organ damage. At Infusion Center of DE, specialized infusion therapies are offered to support the recovery process and improve the quality of life for those with Wegener’s disease.
The treatment for Wegener’s disease (Granulomatosis with Polyangiitis) typically involves a combination of medications such as immunosuppressants, corticosteroids, and sometimes biologic drugs to reduce inflammation and manage symptoms. In some cases, patients may require chemotherapy to control the disease. Infusion therapies, which are offered at Infusion Center of DE, can also play a crucial role in managing symptoms and improving quality of life for those with Wegener’s disease.
The symptoms of Wegener’s disease (Granulomatosis with Polyangiitis) can vary, but commonly include fatigue, fever, weight loss, sinusitis, cough, shortness of breath, and kidney problems. Other symptoms may affect the skin, ears, or eyes. If left untreated, the disease can cause severe organ damage. At Infusion Center of DE, treatments like infusion therapies can help manage these symptoms and improve quality of life for those affected by Wegener’s disease.
Living with GPA? You don't have to manage it alone.
Granulomatosis with Polyangiitis requires early diagnosis, individualized treatment, and ongoing medical management. Regular monitoring and prompt attention to new symptoms remain essential to long-term disease control.
Specialized Infusion Care for Wegeners
Expert, personalized treatment at the Infusion Center of DE. Schedule now.